MRM Health Launches Phase 2b UC Trial with MH002
GHENT, Belgium, May 2, 2026 MRM Health announced the initiation of its Phase 2b STARFISH-UC clinical trial (NCT07296315) evaluating...
clinical trial
Advertisement
AstraZeneca TRUQAP Gains FDA Panel Support in Prostate Cancer
WASHINGTON, D.C., April 30, 2026 AstraZeneca announced that the U.S. Food and Drug Administration’s Oncologic Drugs Advisory Committee (ODAC)...
Bambusa Therapeutics Completes BBT001 Trial Enrollment
BOSTON, MASSACHUSETTS, April 30, 2026 Bambusa Therapeutics has announced the successful completion of patient enrollment in its Phase 1b/2a...
EnGeneIC Doses First Patient in GBM EDV Therapy Trial
SYDNEY, AUSTRALIA, May 01, 2026 EnGeneIC has announced a critical clinical milestone with the first patient dosed in its...
Laguna Gains FDA IND Clearance for LGNA-100 Therapy
SAN FRANCISCO, CALIFORNIA, April 29, 2026 Laguna Biotherapeutics has announced that the U.S. Food and Drug Administration (FDA) has...
Advertisements
Kestrel Therapeutics Doses First Patient in KRAS Trial
WATERTOWN, MASSACHUSETTS, April 28, 2026 Kestrel Therapeutics Inc. has announced a major clinical milestone with the first patient dosed...
InnoCare Advances Phase III Orelabrutinib Trial for SLE
BEIJING, April 29, 2026 InnoCare Pharma has announced that the first patient has been dosed in the registrational Phase...
Cellenkos Wins FDA Clearance for CK0801 Phase 2 Trial
HOUSTON, TEXAS, April 27, 2026 Cellenkos Inc. has received U.S. Food and Drug Administration (FDA) clearance to initiate a...
Galaxy Therapeutics Submits PMA for SEAL Device FDA
MILPITAS, CALIFORNIA, April 27, 2026 Galaxy Therapeutics has announced the submission of the final module of its Premarket Approval...
Adagio Medical Reports Positive vCLAS Results for VT
LOS ANGELES, April 2026 Adagio Medical announced positive pivotal clinical results for its vCLAS® Ventricular Ablation System, highlighting a...
Advertisement
